: Pfizer vaccine’s -70° Celsius storage requirement will be a challenge for India, says AIIMS director #IndiaNEWS All India Institute of Medical Sciences Director Randeep Guleria on Wednesday that

Pfizer vaccine’s -70° Celsius storage requirement will be a challenge for India, says AIIMS director #IndiaNEWS
All India Institute of Medical Sciences Director Randeep Guleria on Wednesday that it will be a challenge for countries like India to store and supply American pharmaceutical firm Pfizer’s coronavirus vaccine, which needs to kept at minus 70 degree Celsius, ANI reported. “We’ll have difficulties in maintaining a cold chain, especially on rural missions,??? he was quoted as saying by the news agency. “Overall [it is] encouraging news in vaccine research for those in Phase III trials.???Pfizer and German biotechnology company BioNTech on Monday announced that their coronavirus vaccine was more than 90% effective in phase-3 clinical trials. The news had ignited hope, as the world continues efforts to develop a vaccine against the disease.In an interview to Scroll.in on Tuesday, medical scientist Dr Gagandeep Kang had also spoken about the cost and storage-related challenges of the vaccine. She had said that since Pfizer’s vaccine was an mRNA (messenger ribonucleic acid) vaccine, it would be expensive. Dr Kang added that India currently had no system to deliver a “minus 80 degree Celsius vaccine???. Also read: Interview: Why Pfizer’s Covid-19 vaccine will be expensive and difficult to deliver in IndiaWe know Pfizer’s Covid vaccine works. But how well it works is still unknownT Sundararaman, the coordinator of People’s Health Movement in Delhi, spoke to...Read more

Stock Market NEWS Best intraday tips Intraday Stocks below 100